UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7566-7566

2021

Volltextzugriff (PDF)

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1870-1870

2013

Volltextzugriff (PDF)

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5899-5899

2017

Volltextzugriff (PDF)

Abstract 6782: Spatial transcriptomics of serous tubal intraepithelial carcinoma and its putative precursor lesions

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6782-6782

2023

Volltextzugriff (PDF)

Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.A107-A107

2024

Volltextzugriff (PDF)

Abstract CT-05: A phase II trial of selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.CT-05-CT-05

2012

Volltextzugriff (PDF)

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-097-NT-097

2019

Volltextzugriff (PDF)

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.TMEM-118-TMEM-118

2017

Volltextzugriff (PDF)

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Volltextzugriff (PDF)

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

JCO oncology practice, 2020-08, Vol.16 (8), p.483-489

2020

Volltextzugriff (PDF)

ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.430-431

2021

Volltextzugriff (PDF)

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer, 2011-06, Vol.117 (12), p.2643-2651

2011

Volltextzugriff (PDF)

Cancer of the endometrium and corpus uteri

Current opinion in obstetrics & gynecology, 1998-02, Vol.10 (1), p.57-60

1998

Volltextzugriff (PDF)

Chemotherapy response score as a prognostic tool in advanced-stage endometrial cancer patients treated with neoadjuvant chemotherapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18095-e18095

2020

Volltextzugriff (PDF)

Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy

International journal of gynecological cancer, 2021-06, Vol.31 (6), p.852-858

2021

Volltextzugriff (PDF)

The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction

Annals of surgical oncology, 2020-06, Vol.27 (6), p.1737-1740

2020

Volltextzugriff (PDF)

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Contemporary ob/gyn, 2022-04, Vol.67 (4), p.18

2022

Volltextzugriff (PDF)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model

mBio, 2022-02, Vol.13 (1), p.e0304421-e0304421

2022

Volltextzugriff (PDF)

Combination of DXA and BIS body composition measurements is highly correlated with physical function—an approach to improve muscle mass assessment

Archives of osteoporosis, 2018-09, Vol.13 (1), p.97-97, Article 97

2018

Volltextzugriff (PDF)

Correlation of Tumor ARID1A Mutations, BRAF V600E Mutations and Microsatellite Instability in Sporadic and Tamoxifen-Associated High Grade Endometrial Cancer

American journal of clinical pathology, 2013-09, Vol.140 (suppl_1), p.A010-A010

2013

Volltextzugriff (PDF)

Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7795-7806

2021

Volltextzugriff (PDF)

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Annals of surgical oncology, 2021-05, Vol.28 (12), p.7795-7806

2021

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaOvarian Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(93)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Abstract 6782: Spatial transcriptomics of serous tubal intraepithelial carcinoma and its putative precursor lesions

Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

Abstract CT-05: A phase II trial of selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives

ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer of the endometrium and corpus uteri

Chemotherapy response score as a prognostic tool in advanced-stage endometrial cancer patients treated with neoadjuvant chemotherapy

Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy

The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction

The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model

Combination of DXA and BIS body composition measurements is highly correlated with physical function—an approach to improve muscle mass assessment

Correlation of Tumor ARID1A Mutations, BRAF V600E Mutations and Microsatellite Instability in Sporadic and Tamoxifen-Associated High Grade Endometrial Cancer

Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Aktive Filter

Suchergebnisse filtern